thiophenes has been researched along with Cerebral Hemorrhage in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 20 (83.33) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Corsi, FM; Gerace, C; Ricci, M | 1 |
| Bastovansky, A; Finsterer, J; Stöllberger, C; Zuntner, G | 1 |
| Bauer, KA | 1 |
| Gómez de Diego, JJ; López Sendón, JL; Montoro López, N; Peña Conde, L | 1 |
| Uchiyama, S | 1 |
| Heitmeier, S; Jenetzky, E; Ploen, R; Sun, L; Veltkamp, R; Zhou, W; Zorn, M | 1 |
| Arrich, J; Gouya, G; Gurbel, PA; Huber, K; Pirker-Kees, A; Siller-Matula, JM; Verheugt, FW; Wolzt, M | 1 |
| Hanon, O | 1 |
| Behrens, L; Capper, D; Purrucker, JC; Veltkamp, R | 1 |
| Hess, T; Konturek, P | 1 |
| Berthold, C; Boecher-Schwarz, H; Dooms, G; Gunness, VR; Hana, A; Hertel, F; Koy, J; Matgé, G; Standhardt, H | 1 |
| Baba, Y; Hagii, J; Hitomi, H; Iwata, M; Kamada, T; Matsumoto, S; Metoki, N; Okumura, K; Osanai, T; Saito, S; Sasaki, S; Seino, S; Shiroto, H; Takahashi, K; Tomita, H; Uchizawa, T; Yasujima, M | 1 |
| Akdemir, HU; Akdemir, N; Başara, G; Çalışkan, F; Nurata, H; Yavuz, Y | 1 |
| Braccini, T; Grandgirard, D; Koedel, U; Leib, SL; Oggioni, MR; Ricci, S; Salvatore, P; Wenzel, M | 1 |
| Akbari, SH; Cross, DT; Kadkhodayan, Y; Moran, CJ; Reynolds, MR | 1 |
| Chandra, RV; Hirsch, JA; Leslie-Mazwi, TM; Rabinov, JD; Yoo, AJ | 1 |
| Diener, HC; Harenberg, J; Lip, GY; Marder, VJ; Marx, S; Wehling, M; Weiss, C | 1 |
| Hui, AC; James, P; Jameson, SS; Muller, SD; Rymaszewska, M; Serrano-Pedraza, I | 1 |
| Okada, Y; Yasaka, M | 1 |
| Bütehorn, U; Heitmeier, S; Nawroth, P; Perzborn, E; Veltkamp, R; Zhou, W; Zorn, M | 1 |
| Grove, EL; Husted, SE; Kraglund, KL; Modrau, B | 1 |
| Grossetete, M; Rosenberg, GA | 1 |
| Chapman, DF; Lapchak, PA; Zivin, JA | 1 |
| Lo, EH; Sumii, T | 1 |
7 review(s) available for thiophenes and Cerebral Hemorrhage
| Article | Year |
|---|---|
Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Humans; Monitoring, Physiologic; Morpholines; Prodrugs; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thrombin; Thromboembolism; Vitamin K; Warfarin | 2013 |
Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
Topics: Adenosine; Aged; Aspirin; Cerebral Hemorrhage; Cerebrovascular Disorders; Clopidogrel; Cohort Studies; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Population; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Secondary Prevention; Stroke; Thiophenes; Ticagrelor; Ticlopidine; Vascular Diseases | 2014 |
[Novel oral anticoagulants and atrial fibrillation in the elderly].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Drugs, Investigational; Half-Life; Humans; Intracranial Embolism; Metabolic Clearance Rate; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Vitamin K | 2013 |
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Embolism; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K; Warfarin | 2014 |
NOAC and intracerebral bleeding--presentation of four cases and review of the literature.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Female; Humans; Hypertension; Male; Morpholines; Rivaroxaban; Thiophenes | 2014 |
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Chi-Square Distribution; Dabigatran; Embolism; Female; Humans; Male; Middle Aged; Morpholines; Myocardial Infarction; Odds Ratio; Pyrazoles; Pyridones; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome | 2012 |
[Anticoagulant therapy in stroke patients].
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Morpholines; Pyrazoles; Pyridones; Radiography; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thiophenes; Thromboembolism; Vitamin K | 2013 |
17 other study(ies) available for thiophenes and Cerebral Hemorrhage
| Article | Year |
|---|---|
Rotigotine effect in prolonged disturbance of consciousness. Brief report of two cases.
Topics: Administration, Cutaneous; Aged; Akinetic Mutism; Cerebral Hemorrhage; Dopamine Agonists; Female; Humans; Male; Middle Aged; Persistent Vegetative State; Recovery of Function; Tetrahydronaphthalenes; Thiophenes | 2020 |
Cerebral hemorrhage under rivaroxaban.
Topics: Aged, 80 and over; Anticoagulants; Cerebral Hemorrhage; Female; Humans; Morpholines; Rivaroxaban; Thiophenes | 2013 |
[Systemic aneurysms in Behçet's disease].
Topics: Adult; Aneurysm, Ruptured; Behcet Syndrome; Cerebral Hemorrhage; Combined Modality Therapy; Coronary Aneurysm; Coronary Restenosis; Drug-Eluting Stents; Humans; Intracranial Aneurysm; Male; Myocardial Ischemia; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Rupture, Spontaneous; Stents; Thiophenes | 2013 |
[How to properly use warfarin and new anticoagulants].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Humans; International Normalized Ratio; Morpholines; Practice Guidelines as Topic; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Warfarin | 2013 |
Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke.
Topics: Animals; Anticoagulants; Blood-Brain Barrier; Brain Ischemia; Cerebral Hemorrhage; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Morpholines; Rats; Rats, Wistar; Rivaroxaban; Stroke; Thiophenes; Thrombolytic Therapy; Time Factors | 2014 |
Secondary hematoma expansion in intracerebral hemorrhage during rivaroxaban therapy.
Topics: Aged; Anticoagulants; Brain; Cerebral Hemorrhage; Fatal Outcome; Female; Hematoma, Subdural, Intracranial; Humans; Morpholines; Neuroimaging; Rivaroxaban; Stroke; Thiophenes; Tomography, X-Ray Computed | 2014 |
Characteristics of intracerebral hemorrhage during rivaroxaban treatment: comparison with those during warfarin.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Retrospective Studies; Risk; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin | 2014 |
Rıvaroxaban-induced severe diffuse ıntracerebral hemorrhage.
Topics: Aged, 80 and over; Cerebral Hemorrhage; Factor Xa Inhibitors; Humans; Male; Morpholines; Rivaroxaban; Thiophenes | 2015 |
Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Cerebellum; Cerebral Hemorrhage; Chemokines; Cytokines; Dentate Gyrus; Disease Models, Animal; Female; Kaplan-Meier Estimate; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Meningitis, Meningococcal; Mice; Phenylalanine; Thiophenes | 2014 |
Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures.
Topics: Adult; Aged; Cerebral Hemorrhage; Embolization, Therapeutic; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Piperazines; Prasugrel Hydrochloride; Purinergic P2X Receptor Antagonists; Radiography; Retrospective Studies; Thiophenes | 2013 |
Hemorrhagic complications with prasugrel therapy for vascular neurointerventional procedures.
Topics: Cerebral Hemorrhage; Embolization, Therapeutic; Endovascular Procedures; Female; Humans; Male; Neuroprotective Agents; Piperazines; Prasugrel Hydrochloride; Purinergic P2X Receptor Antagonists; Purinergic P2Y Receptor Antagonists; Radiography; Thiophenes | 2013 |
Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
Topics: Age Distribution; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cerebral Hemorrhage; Cohort Studies; Confidence Intervals; Databases, Factual; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Morpholines; Odds Ratio; Postoperative Complications; Retrospective Studies; Risk Assessment; Rivaroxaban; Sex Distribution; Surgical Wound Infection; Survival Analysis; Thiophenes; Treatment Outcome; Venous Thrombosis; Wound Healing | 2012 |
[Management of intracranial hemorrhage during anticoagulant therapy with warfarin or novel anticoagulants].
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Humans; Intracranial Embolism; Morpholines; Rivaroxaban; Thiophenes; Warfarin | 2012 |
Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban.
Topics: Animals; Anticoagulants; Blood Coagulation Factors; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Factor VIIa; Hematoma; Hemostatic Techniques; Male; Mice; Mice, Inbred C57BL; Models, Animal; Morpholines; Plasma; Rivaroxaban; Thiophenes; Treatment Outcome | 2013 |
Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.
Topics: Animals; Apoptosis; Blotting, Western; Cerebral Hemorrhage; Gene Expression; In Situ Nick-End Labeling; Male; Matrix Metalloproteinases; Mice; Mice, Knockout; Phenylalanine; Protease Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiophenes; Tissue Inhibitor of Metalloproteinase-3 | 2008 |
Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
Topics: Animals; Cerebral Hemorrhage; Disease Models, Animal; Fibrinolytic Agents; Humans; Intracranial Embolism; Metalloendopeptidases; Phenylalanine; Protease Inhibitors; Rabbits; Stroke; Thiophenes; Thromboembolism; Tissue Plasminogen Activator | 2000 |
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
Topics: Animals; Blood Flow Velocity; Brain; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Circulation; Disease Models, Animal; Enzyme Inhibitors; Intracranial Embolism; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Phenylalanine; Rats; Rats, Inbred SHR; Sodium, Dietary; Survival Rate; Thiophenes; Thrombolytic Therapy; Tissue Plasminogen Activator | 2002 |